NasdaqGS - Nasdaq Real Time Price USD

MBX Biosciences, Inc. (MBX)

12.36
+0.21
+(1.73%)
At close: 4:00:01 PM EDT
12.36
0.00
(0.00%)
After hours: 4:05:08 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
Operating Expense
81,409
68,194
35,311
25,161
Operating Income
-81,409
-68,194
-35,311
-25,161
Net Non Operating Interest Income Expense
7,944
6,272
2,748
-2
Other Income Expense
--
--
--
-972
Pretax Income
-73,465
-61,922
-32,563
-26,135
Net Income Common Stockholders
-73,465
-61,922
-32,563
-26,135
Diluted NI Available to Com Stockholders
-73,465
-61,922
-32,563
-26,135
Basic EPS
-2.20
-5.82
-1.02
-0.82
Diluted EPS
-2.20
-5.82
-1.02
-0.82
Basic Average Shares
33,424.37
10,642.95
31,853.70
31,853.70
Diluted Average Shares
33,424.37
10,642.95
31,853.70
31,853.70
Total Operating Income as Reported
-81,409
-68,194
-35,311
-25,161
Total Expenses
81,409
68,194
35,311
25,161
Net Income from Continuing & Discontinued Operation
-73,465
-61,922
-32,563
-26,135
Normalized Income
-73,465
-61,922
-32,563
-25,163
Interest Income
7,944
6,272
2,748
372
Interest Expense
--
--
0
374
Net Interest Income
7,944
6,272
2,748
-2
EBIT
-81,409
-68,194
-35,311
-25,761
EBITDA
-81,136
-67,950
-35,154
-25,705
Reconciled Depreciation
273
244
157
56
Net Income from Continuing Operation Net Minority Interest
-73,465
-61,922
-32,563
-26,135
Total Unusual Items Excluding Goodwill
--
--
0
-972
Total Unusual Items
--
--
0
-972
Normalized EBITDA
-81,136
-67,950
-35,154
-24,733
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 9/13/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

UPB Upstream Bio, Inc.
9.13
+0.88%
 
RAPP Rapport Therapeutics, Inc.
10.22
+0.29%
 
AVBP ArriVent BioPharma, Inc.
20.86
+7.80%
 
ALMS Alumis Inc.
4.8800
-17.98%
 
BCAX Bicara Therapeutics Inc.
15.04
-1.12%
 
CTNM Contineum Therapeutics, Inc.
3.8300
-12.36%
 
SYRE Spyre Therapeutics, Inc.
15.40
+3.49%
 
VALN Valneva SE
6.41
+0.47%
 
BOLD Boundless Bio, Inc.
1.6600
-1.78%
 
ARTV Artiva Biotherapeutics, Inc.
2.1600
+6.93%